IL233290A0 - Composition, preparation, and use of dense chitosan membrane materials - Google Patents

Composition, preparation, and use of dense chitosan membrane materials

Info

Publication number
IL233290A0
IL233290A0 IL233290A IL23329014A IL233290A0 IL 233290 A0 IL233290 A0 IL 233290A0 IL 233290 A IL233290 A IL 233290A IL 23329014 A IL23329014 A IL 23329014A IL 233290 A0 IL233290 A0 IL 233290A0
Authority
IL
Israel
Prior art keywords
preparation
composition
membrane materials
chitosan membrane
dense chitosan
Prior art date
Application number
IL233290A
Other languages
Hebrew (he)
Original Assignee
Agenta Biotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agenta Biotechnologies Inc filed Critical Agenta Biotechnologies Inc
Publication of IL233290A0 publication Critical patent/IL233290A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/00272-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/722Chitin, chitosan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances
    • C08J3/02Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075Macromolecular gels
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/08Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL233290A 2011-12-22 2014-06-22 Composition, preparation, and use of dense chitosan membrane materials IL233290A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161579003P 2011-12-22 2011-12-22
PCT/US2012/070617 WO2013096448A1 (en) 2011-12-22 2012-12-19 Composition, preparation, and use of dense chitosan membrane materials

Publications (1)

Publication Number Publication Date
IL233290A0 true IL233290A0 (en) 2014-08-31

Family

ID=48669446

Family Applications (1)

Application Number Title Priority Date Filing Date
IL233290A IL233290A0 (en) 2011-12-22 2014-06-22 Composition, preparation, and use of dense chitosan membrane materials

Country Status (7)

Country Link
EP (1) EP2793908A4 (en)
JP (1) JP2015511214A (en)
KR (1) KR20140122231A (en)
CN (1) CN104144692A (en)
BR (1) BR112014015444A2 (en)
IL (1) IL233290A0 (en)
WO (1) WO2013096448A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103893204B (en) * 2014-04-03 2016-05-11 石家庄亿生堂医用品有限公司 A kind of preparation method of chitosan hydrochloride calcium styptic powder
WO2017099261A1 (en) * 2015-12-07 2017-06-15 주식회사 글로원 Method for preparing scaffold by using salt leaching and immersion precipitation methods, and scaffold thereof
WO2017122216A1 (en) * 2016-01-14 2017-07-20 Amnivor Medicare Private Limited A process for extraction of collagen from fish scale and polyelectrolyte based bioactive super-absorbent materials
CN106046398A (en) * 2016-06-22 2016-10-26 深圳普洛美康材料有限公司 Hydrogel and preparation method thereof
WO2018083643A1 (en) * 2016-11-04 2018-05-11 Axio Biosolutions Pvt. Ltd Mucoadhesive preparations, methods and applications thereof
WO2019051750A1 (en) * 2017-09-14 2019-03-21 谭玲 Method for preparing polyethylene glycol modified chitosan film
JP6933394B2 (en) * 2018-09-06 2021-09-08 マリン エッセンス バイオサイエンシズ コーポレーション オブ ユーエスエーMarine Essence Biosciences Corporation of USA Biomaterial devices and topical compositions for inducing tissue regeneration
KR102205564B1 (en) * 2019-03-08 2021-01-22 주식회사 제론바이오 PDRN encapsulated chitosan nanoparticles included chitosan nanofilm and a method for preparing the same
CN111234289B (en) * 2020-02-11 2022-04-01 南通大学 Anti-adhesion polyformaldehyde ligation hemostatic clamp and preparation method and application thereof
KR102256257B1 (en) * 2020-04-21 2021-05-26 한국화학연구원 A chiral Nitrogen-doped nematic carbon-sheath nanofiber, method for its preparation, and use thereof
CN114306714B (en) * 2021-12-31 2022-08-02 安徽科门生物科技有限公司 Method for preparing stem cell composite biological material for skin regeneration and repair
CN115252879A (en) * 2022-07-13 2022-11-01 肖地生 Preparation method and application of chitosan hemostatic material

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020131933A1 (en) * 1996-01-16 2002-09-19 Yves Delmotte Biopolymer membrane and methods for its preparation
US6271278B1 (en) * 1997-05-13 2001-08-07 Purdue Research Foundation Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties
US6740752B2 (en) * 2000-05-12 2004-05-25 The Procter & Gamble Company Process for preparing chitosan particles
US7371403B2 (en) * 2002-06-14 2008-05-13 Providence Health System-Oregon Wound dressing and method for controlling severe, life-threatening bleeding
US7536962B2 (en) * 2005-04-19 2009-05-26 Kamterter Ii, L.L.C. Systems for the control and use of fluids and particles

Also Published As

Publication number Publication date
EP2793908A4 (en) 2015-08-19
BR112014015444A2 (en) 2017-07-04
EP2793908A1 (en) 2014-10-29
JP2015511214A (en) 2015-04-16
KR20140122231A (en) 2014-10-17
CN104144692A (en) 2014-11-12
WO2013096448A1 (en) 2013-06-27

Similar Documents

Publication Publication Date Title
IL233290A0 (en) Composition, preparation, and use of dense chitosan membrane materials
IL250824B (en) Certain amino-pyridazines, compositions thereof, and methods of their use
ZA201309669B (en) Immunoconjugates,composition containing them,and methods of making and use
ZA201209739B (en) Levocarrimycin,pharmaceutical compositions,preparation methods and uses thereof
EP2702054A4 (en) Novel bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use
HK1202415A1 (en) Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15- hetre and methods of use thereof dgla15-ohepa/ 15-hetre
EP2530079A4 (en) Phenyl c-glucoside derivatives, preparation methods and uses thereof
EP2688688A4 (en) Aqueous, nitrogen-free cleaning composition, preparation and use thereof
EP2718331A4 (en) N,n,n-trialkylpolymers, methods of their preparation and uses thereof
EP2621966A4 (en) Elastic, moisture-vapor permeable films, their preparation and their use
EP2550954A4 (en) Vaseline-like composition, and cosmetic preparation
HK1182934A1 (en) Anti-fatigue composition, formulation and use thereof
ZA201207178B (en) Oxadiazole compounds,their preparation and use
EP2687539A4 (en) Annexin v variant, and preparation and use thereof
EP2766375A4 (en) Preparation of novel fluorocompounds, methods of preparation and compositions made therefrom
EP2742020A4 (en) N1-cyclic amine-n5-substituted biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same
EP2671878A4 (en) Substituted n-pentanamide compounds, preparation methods and uses thereof
EP2757092A4 (en) Substituted cyanoaniline compounds, preparation and use thereof
IL221730A0 (en) Derivatives of aminoindanes, their preparation and their application in therapeutics
EP2738159A4 (en) Mercapto-benzophenone compounds, compositions and preparation methods thereof
EP2903979A4 (en) Novel compounds, their preparation and their uses
EP2525900A4 (en) Nitrogen-permeable membranes and uses thereof
EP2766183A4 (en) Iron-fiber composition, preparation and uses thereof
EP2701689A4 (en) Pharmaceutical compositions of raltegravir, methods of preparation and use thereof
HK1199374A1 (en) Shirring composition and uses thereof